BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T014329
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014329
CREATED:20211213T100512Z
LAST-MODIFIED:20220316T101306Z
UID:32486-1650931200-1651190399@www.pharmajournalist.com
SUMMARY:2nd Ligase Targeting Drug Development Summit
DESCRIPTION:Whilst the exploiting of this therapeutic modality surges through biopharma and academia\, it is essential that we unlock the fundamental challenges within this industry\, as this remains a key factor determining success of degraders in the clinic. \n \nThe 2nd Ligase Targeting Drug Development Summit returns to Boston in April again uniting industry frontiers and leading minds\, as together we discuss\, update\, and learn how to successfully hijack ligases for therapeutic application\, and uncover a critical piece of the puzzle in realizing the full potential of this therapeutic approach. \nFilling the gap of an industry-led ubiquitin discussion\, we again provide an unrivalled forum to unite leading biopharmaceutical giants\, alongside key academics\, to share unseen data\, collaborative efforts and discuss next steps to successfully select\, validate and translate E3’s into a viable therapy. \nJoin us in Boston to expand your understanding of the ever-broadening ligases field and the fast-improving chemical biology tools to seize the therapeutic value of Ubiquitin E3 ligases and differentiate your pipelines. \nTo Know more visit: https://ter.li/rm8y7d
URL:https://www.pharmajournalist.com/event/2nd-ligase-targeting-drug-development-summit/
LOCATION:Online\, EDT
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014329
CREATED:20220125T093551Z
LAST-MODIFIED:20220125T093551Z
UID:32942-1650931200-1651190399@www.pharmajournalist.com
SUMMARY:5th Neoantigen Summit Europe
DESCRIPTION: The 5th Neoantigen Summit Europe\, the definitive industry meeting for uncovering the full potential of neoantigens in creating individualised neoantigen vaccines is returning in person! \nFrom understanding the latest clinical insights to reviewing vaccines post-COVID\, our 35+ expert speakers and 3-day agenda developed alongside #Vaccibody\, #Gritstonebio\, #Targovax\, #Vaximm\, #Immunetune and #OdimmaTherapeutics will help you advance your pipeline to successfully weaponise neoantigens for anti-tumour treatment. \nJoin 100+ colleagues and take on the next frontier in neoantigen identification and vaccine manufacturing. \nKey speakers include: Agnete Fredriksen\, Chief Innovation & Strategy Officer\, Nykode Therapeutics | Barbara Loesch\, Head of Technology and Innovation\, Medigene |Jessica Matta\, Co-Founder & Chief Executive Officer & Chief Scientific Officer\, Odimma therapeutics | Andrew Allen\, CEO\, Gritstone bio | Peter Sondermann\, CEO\, Tacalyx GmbH |Sijme Zeilemaker\, Chief Executive Officer\, Immunetune \nFind out more in the event guide here: https://ter.li/gulg78 \nVisit the official event website here: https://ter.li/s89k61
URL:https://www.pharmajournalist.com/event/5th-neoantigen-summit-europe/
LOCATION:Leonardo Royal Amsterdam\, Paul van Vlissingenstraat 24\, Amsterdam\, 1096 BK\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014329
CREATED:20220201T115212Z
LAST-MODIFIED:20220201T115212Z
UID:33082-1650931200-1651190399@www.pharmajournalist.com
SUMMARY:6th R&D Sourcing & Procurement Summit in Pharma
DESCRIPTION:We are excited for the 6th Advanced R&D Procurement & Sourcing in Pharma Summit returning to Boston in April\, reuniting senior leaders to share their stories and lessons learned\, and how they implement strategic sourcing to optimize spending and mitigate risks. \nAs the one and only community dedicated to 100+ R&D procurement\, category management\, and sourcing professionals\, this is your must-attend conference in 2022 to benchmark your SOPs against your peers and stay at the forefront of technology to streamline your procurement processes. Leave this meeting with practical tips to drive scientific innovations with sustainability\, optimized spend and strengthened vendor relationships! \nYour Unmissable Spotlight Case Studies In 2022: \n\nEstablish robust external supplier relationship models to advance your pipeline development with Betrand Rosier\, Global Procurement Head\, Sanofi\nRebrand procurement to be your scientists’ best business partner with Gerard Cardillo\, Vice President\, Global Procurement\nExplore lessons learned from COVID including strategic investing with Sean Cumbie\, Vice President\, Global Sourcing & Procurement\, NOVAVAX\nDevelop sourcing & procurement strategies at lightspeed with James Tornos\, Vice President\, Sourcing & Enterprise Services – Research\, Development and Medical Procurement\, Pfizer\nDeep-dive into driving D&I initiatives\, both within companies and through supplier diversity initiatives in an exclusive\, interactive workshop led by Manuele Burdese\, Senior Director\, Head of Business Insights & Analytics Strategic Sourcing & Procurement\, Bristol Myers Squibb\, Tom Thattacherry\, Head\, Supplier Diversity\, Genentech\n\nTo find out how you and your team can get involved download your free event guide or get in touch.
URL:https://www.pharmajournalist.com/event/6th-rd-sourcing-procurement-summit-in-pharma/
LOCATION:The Bostonian Boston\, 26 NORTH STREET\, BOSTON\, MA\, 02109\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:monica.mojumder-chan@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220427
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014329
CREATED:20220131T115758Z
LAST-MODIFIED:20220131T115758Z
UID:33066-1651017600-1651190399@www.pharmajournalist.com
SUMMARY:SMi’s 5th Annual Pharmaceutical Microbiology East Coast Conference
DESCRIPTION:SMi’s 5th Annual Pharmaceutical Microbiology East Coast Conference\nConference: 27 – 28 April 2022\nWorkshops: 29 April 2022\nBoston\, MA\, USA\nhttp://www.microbiologyeastcoast.com/PJwl \nSponsored by: Bioscience International\, Associates of Cape Cod and Microbiologics \nChaired by: Jim Polarine\, Senior Technical Service Manager\, Head of Microbiology & Sterile Technology\, STERIS Corporation \nHarnessing existing methods and novel tools in microbial control to assure continuity in product quality and patient safety \nSMi’s 5th Annual Pharmaceutical Microbiology East Coast Conference is taking place in Boston on April 27-28\, 2022\, with interactive workshops on April 26\, 2022. \nMicrobiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals\, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches. \nEnsuring the sterility of the finished product continues to be one of the most critical aspects of drug development\, however an array of factors are also sustaining new growth and transformation in this field. The regulatory landscape is changing\, firstly with the preparation of Annex 1\, in addition to increasing requirements pertaining to data integrity. Light is being shed on recent product recalls for mould contamination\, and infection outbreaks serve as a reminder to pay more attention to these overlooked organisms\, as well as considerations towards container closure integrity testing which is being increasingly deployed to block microbe movement. \nOn top of this\, the developing integration of automation and robotics into the manufacturing pipeline\, as well as the increased need for more rapid microbiology methods brought about in part by the surge in ATMPs\, are all highlighting the necessity of the field in Pharma.  \nThis industry is ever expanding\, join leading experts in 2022 to discuss and analyse the latest advances and challenges surrounding Pharmaceutical Microbiology. Network with industry professionals\, discuss revisions in regulatory and guidance documents\, and gain a deeper insight into this corner of the field.\nEvent Hashtag: #SMiPharmaMicroEC  \nKey Highlights for 2022:  \n\nReview implementation guidance and validation for efficient disinfectant efficacy programs\nUncover principles in best-practice and the benefits of a robust contamination control strategy\nAddress fungal mould contamination and risk-based tools to tackle spore spreading\nDelve into the sterility assurance assessment and holistic closure integrity testing\nExplore the impact of the ongoing pandemic and the changing face of the pharma industry\nUnderstand new unique case studies\, from contamination control as it relates to microbiome products\, to risk-based assessments of traditional microbiological tests\n2 Interactive Pre-Conference Workshops on April 26\, 2022\n\nInteractive Workshops: \nWorkshop A: Risk Assessment and Cleaning Validation \nWorkshop Leader: Fred Ohsiek\, SME\, Cleaning Validation\, North America \nWorkshop B: USP Microbiology 2022 – Keeping Up with Standards \nWorkshop Leader: Donald Singer\, Chair\, General Chapters – Microbiology Expert Committee\, US Pharmacopeia and Ecolab Life Sciences \nView the full agenda: http://www.microbiologyeastcoast.com  \nWHO SHOULD ATTEND? \nSenior Microbiologist\, Lead Scientist\, Laboratory Manager\, QA Specialist\, Drug Substance External Manufacturer\, QC Scientists\, Heads of Quality\, Business Development Manager\, Pharmaceutical Microbiology Consultant\, Higher Pharmacopoeia Scientist\, Analytical Standards Specialist
URL:https://www.pharmajournalist.com/event/smis-5th-annual-pharmaceutical-microbiology-east-coast-conference/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Events":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
END:VCALENDAR